| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-04 19:03:26 UTC |
|---|
| Update Date | 2021-09-14 15:45:15 UTC |
|---|
| HMDB ID | HMDB0060851 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | N,O-Didesmethyltramadol |
|---|
| Description | N,O-Didesmethyltramadol, also known as M5, belongs to the class of organic compounds known as cyclohexylphenols. Cyclohexylphenols are compounds containing a cyclohexane lined to a phenol group. N,O-Didesmethyltramadol is a very strong basic compound (based on its pKa). Within humans, N,O-didesmethyltramadol participates in a number of enzymatic reactions. In particular, N,O-didesmethyltramadol and formaldehyde can be biosynthesized from N-desmethyltramadol; which is catalyzed by the enzyme cytochrome P450 2D6. In addition, N,O-didesmethyltramadol and formaldehyde can be biosynthesized from O-desmethyltramadol through its interaction with the enzyme cytochrome P450 2D6. N,O-Didesmethyltramadol is a metabolite of tramadol. The drug has a wide range of applications, including treatment of rheumatoid arthritis, restless legs syndrome, and fibromyalgia. In humans, N,O-didesmethyltramadol is involved in tramadol metabolism pathway. Tramadol hydrochloride (trademarked as Conzip, Ryzolt, Ultracet, Ultram in the USA; Ralivia and Zytram XL in Canada) is a centrally-acting synthetic analgesic used to treat moderate to moderately-severe pain. It was launched and marketed as Tramal by the German pharmaceutical company Grnenthal GmbH in 1977 (Wikipedia). |
|---|
| Structure | CNC[C@H]1CCCC[C@]1(O)C1=CC(O)=CC=C1 InChI=1S/C14H21NO2/c1-15-10-12-5-2-3-8-14(12,17)11-6-4-7-13(16)9-11/h4,6-7,9,12,15-17H,2-3,5,8,10H2,1H3/t12-,14+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| O,N-Didemethyltramadol | HMDB | | O,N-Didesmethyltramadol | HMDB | | M5 | HMDB |
|
|---|
| Chemical Formula | C14H21NO2 |
|---|
| Average Molecular Weight | 235.322 |
|---|
| Monoisotopic Molecular Weight | 235.157228921 |
|---|
| IUPAC Name | 3-[(1R,2R)-1-hydroxy-2-[(methylamino)methyl]cyclohexyl]phenol |
|---|
| Traditional Name | 3-[(1R,2R)-1-hydroxy-2-[(methylamino)methyl]cyclohexyl]phenol |
|---|
| CAS Registry Number | 144830-18-2 |
|---|
| SMILES | CNC[C@H]1CCCC[C@]1(O)C1=CC(O)=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C14H21NO2/c1-15-10-12-5-2-3-8-14(12,17)11-6-4-7-13(16)9-11/h4,6-7,9,12,15-17H,2-3,5,8,10H2,1H3/t12-,14+/m1/s1 |
|---|
| InChI Key | CJXNQQLTDXASSR-OCCSQVGLSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cyclohexylphenols. Cyclohexylphenols are compounds containing a cyclohexane lined to a phenol group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Cyclohexylphenols |
|---|
| Direct Parent | Cyclohexylphenols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclohexylphenol
- Cyclohexanol
- Phenol
- Aralkylamine
- 1-hydroxy-2-unsubstituted benzenoid
- 1-hydroxy-4-unsubstituted benzenoid
- Tertiary alcohol
- Cyclic alcohol
- Secondary amine
- Secondary aliphatic amine
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Alcohol
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm √ó 2.1 mm; 1.7 Œºmparticle diameter). Predicted by Afia on May 17, 2022. | 2.68 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3366 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.83 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 797.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 206.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 122.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 104.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 296.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 302.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 785.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 674.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 186.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 797.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 168.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 236.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 688.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 402.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 152.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N,O-Didesmethyltramadol,1TMS,isomer #1 | CNC[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O)=C1 | 2061.8 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,1TMS,isomer #2 | CNC[C@H]1CCCC[C@]1(O)C1=CC=CC(O[Si](C)(C)C)=C1 | 2076.9 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,1TMS,isomer #3 | CN(C[C@H]1CCCC[C@]1(O)C1=CC=CC(O)=C1)[Si](C)(C)C | 2217.7 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TMS,isomer #1 | CNC[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1 | 2092.9 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TMS,isomer #2 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O)=C1)[Si](C)(C)C | 2176.0 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TMS,isomer #3 | CN(C[C@H]1CCCC[C@]1(O)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2179.6 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2176.8 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2263.3 | Standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2307.0 | Standard polar | 33892256 | | N,O-Didesmethyltramadol,1TBDMS,isomer #1 | CNC[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O)=C1 | 2300.4 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,1TBDMS,isomer #2 | CNC[C@H]1CCCC[C@]1(O)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2326.6 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,1TBDMS,isomer #3 | CN(C[C@H]1CCCC[C@]1(O)C1=CC=CC(O)=C1)[Si](C)(C)C(C)(C)C | 2471.0 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TBDMS,isomer #1 | CNC[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2520.5 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TBDMS,isomer #2 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O)=C1)[Si](C)(C)C(C)(C)C | 2659.5 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,2TBDMS,isomer #3 | CN(C[C@H]1CCCC[C@]1(O)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2676.7 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TBDMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2864.9 | Semi standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TBDMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2921.8 | Standard non polar | 33892256 | | N,O-Didesmethyltramadol,3TBDMS,isomer #1 | CN(C[C@H]1CCCC[C@]1(O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2617.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N,O-Didesmethyltramadol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9730000000-1723c89493b2caae724f | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N,O-Didesmethyltramadol GC-MS (2 TMS) - 70eV, Positive | splash10-01ox-6049000000-b5b87e37310bf5e1de81 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N,O-Didesmethyltramadol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 10V, Positive-QTOF | splash10-00kr-0190000000-619eeceb75338ebbdc03 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 20V, Positive-QTOF | splash10-052r-4790000000-d5323d821498effc82f6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 40V, Positive-QTOF | splash10-0pvl-9200000000-c5c1ec5f1e2c1d14561a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 10V, Negative-QTOF | splash10-001i-0090000000-e1a59bf22492c8844081 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 20V, Negative-QTOF | splash10-001l-4790000000-98a9934098edb0899334 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,O-Didesmethyltramadol 40V, Negative-QTOF | splash10-0006-9510000000-6d17e0f6fee1b54396b7 | 2017-10-06 | Wishart Lab | View Spectrum |
|
|---|